- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: December 2017
- Public Summary Document (PSD) December 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) December 2017 PBAC Meeting - Word
Cabozantinib – December 2017
Cabozantinib: Tablet 20 mg; Cabometyx®
Last updated
13 April 2018